 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CDSL formed long bullish candlestick pattern on the daily timeframe with healthy volumes. The stock traded far above key moving averages, with momentum indicator RSI (relative strength index) at 80 levels, indicating overbought zone.

Trade Spotlight | What should be your strategy for Aegis Logistics, Metropolis Healthcare, CDSL today?

The company has positioned itself as a premium diagnostics player. The premium wellness category was its fastest-growing segment in Q2

Metropolis Healthcare to spend Rs 50-55 crore over two years to expand

After Covid-19, India's approach to healthcare has shifted towards prevention and this is benefitting diagnostic companies

Indian diagnostic sector set for double-digit growth in medium term: CareEdge Ratings

Metropolis Consolidated September 2023 Net Sales at Rs 308.50 crore, up 2.71% Y-o-Y

Metropolis Standalone September 2023 Net Sales at Rs 285.46 crore, up 1.93% Y-o-Y

The EBITDA margin was at 24.3 percent against 26.3 percent in the year-ago period.

Metropolis Healthcare shares up 3% despite 11.9% decline in Q2 profit

The diagnostic services provider's operations predominantly relate to providing diagnostic services in pathology services.

Metropolis Healthcare Q2 results: Net Profit down 11.9% to Rs 35.5 crore

For a further up-move, the index needs to close above a bearish gap created on September 21 in the 19,850-19,900 zone for a move towards the 20,000 mark, whereas on the lower side, the immediate support will be at 19,600, followed by 19,500, experts said

10 best bets for 3-4 weeks as quarterly earnings, geopolitics to keep markets in a range

Q2 earnings: Core business revenue grew by 13 percent Year on Year, driven by volume growth, demonstrating strong customer acquisition.

Q2 performance: Metropolis Healthcare reports double digit growth, shares gain 2%

Overall, the index has still been in the range with 19,750-19,800 likely to act as a crucial resistance as breaking of the same can drive the Nifty50 towards 20,000 mark, whereas 19,500 is expected to be immediate support and 19,200 may be crucial support for the index, experts said

Ten best bets for Oct series as bulls may charge when Nifty holds 19,800

Metropolis Healthcare Ltd. owns and operates medical laboratories. The firm operates through Pathology Services. It offers comprehensive testing in the areas of genetics biochemistry, molecular oncology, anatomic pathology, microbiology, hematology, and immunochemistry. The company was founded by Sushil Kanubhai Shah and Gomathi Babu Sadacharam Kulandai Velu in 1981 and is headquartered in Mumbai, India.

Watchers	94
52-Wk Low	1,171.35
52-Wk High	1,711.50

Market Cap	86.46B
Volume (M)	238,777.00
52-Wk High	1,711.50
52-Wk Low	1,171.35

METROPOLIS.NSE Metropolis Healthcare Ltd.

About

Feed

News

Sentiment

Fundamentals

Sentiment

Message Volume

Community